Carregant...

Triple-negative breast cancer: are we making headway at least?

The so-called triple-negative breast cancer, as defined by tumors that lack estrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 (HER2) overexpression, has generated growing interest in recent years despite representing less than 20% of all breast cancers. These tumo...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Arnedos, Monica, Bihan, Celine, Delaloge, Suzette, Andre, Fabrice
Format: Artigo
Idioma:Inglês
Publicat: SAGE Publications 2012
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3384094/
https://ncbi.nlm.nih.gov/pubmed/22754593
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758834012444711
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!